TPST
Tempest Therapeutics, Inc.
Company overview
- Market capitalization
- $12.31M
- Employees
- 5
- Latest publication
- 2026-09-29
About Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 486,000USD | 486,000USD | 0USD | 0USD |
| Cost Of Revenue | 22,180,000USD | 65,000USD | 66,000USD | 67,000USD | 68,000USD | 243,000USD | 98,000USD | 155,000USD |
| Gross Profit | -22,180,000USD | -65,000USD | -66,000USD | -67,000USD | -68,000USD | 243,000USD | -98,000USD | -155,000USD |
| Research Development | 114,000USD | 538,000USD | 570,000USD | 3,871,000USD | 7,627,000USD | 10,742,000USD | 7,557,000USD | 5,837,000USD |
| Selling General Administrative | 5,425,000USD | 3,538,000USD | 3,027,000USD | 4,095,000USD | 3,309,000USD | 3,176,000USD | 2,994,000USD | 3,745,000USD |
| Total Operating Expenses | 5,539,000USD | 4,077,000USD | 3,597,000USD | 7,899,000USD | 10,936,000USD | 13,918,000USD | 10,551,000USD | 9,582,000USD |
| Operating Income | -27,719,000USD | -4,077,000USD | -3,597,000USD | -7,966,000USD | -10,936,000USD | -13,918,000USD | -10,551,000USD | -9,582,000USD |
| Interest Income | 23,000USD | 56,000USD | 86,000USD | 142,000USD | 237,000USD | 352,000USD | 324,000USD | 384,000USD |
| Interest Expense | 23,000USD | 86,000USD | 86,000USD | 46,000USD | 161,000USD | 247,000USD | 329,000USD | 372,000USD |
| Net Interest Income | 23,000USD | 56,000USD | 86,000USD | 96,000USD | 76,000USD | 105,000USD | -5,000USD | 12,000USD |
| Income Before Tax | -27,696,000USD | -4,021,000USD | -3,511,000USD | -7,870,000USD | -10,860,000USD | -13,813,000USD | -10,556,000USD | -9,570,000USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income | -27,696,000USD | -4,021,000USD | -3,511,000USD | -7,870,000USD | -10,860,000USD | -13,813,000USD | -10,556,000USD | -9,570,000USD |
| Net Income From Continuing Ops | -27,696,000USD | -4,021,000USD | -3,511,000USD | -7,870,000USD | -10,860,000USD | -13,813,000USD | -10,556,000USD | -9,570,000USD |
| Ebit | -27,696,000USD | -4,021,000USD | -3,511,000USD | -7,824,000USD | -10,699,000USD | -13,566,000USD | -10,227,000USD | -9,198,000USD |
| Ebitda | -27,636,000USD | -3,956,000USD | -3,445,000USD | -7,757,000USD | -10,631,000USD | -13,517,000USD | -10,130,000USD | -9,043,000USD |
| Depreciation And Amortization | 60,000USD | 65,000USD | 66,000USD | 67,000USD | 68,000USD | 49,000USD | 97,000USD | 155,000USD |
| Reconciled Depreciation | 60,000USD | 65,000USD | 66,000USD | 67,000USD | 68,000USD | 49,000USD | 97,000USD | 155,000USD |
| Total Other Income Expense Net | 23,000USD | 56,000USD | 86,000USD | 96,000USD | 76,000USD | 105,000USD | -5,000USD | 12,000USD |
| Selling And Marketing Expenses | — | — | — | — | 88,000USD | 88,000USD | — | 155,000USD |
| Income Tax Expense | — | — | — | — | — | -44,724USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD | FY 20112011-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | — | — | — | — | — |
| Research Development | 12,606,000USD | 17,498,000USD | 14,389,000USD | 27,843,000USD | 14,425,000USD | 15,802,000USD | 6,323,000USD | 1,170,000USD |
| Selling General Administrative | 13,969,000USD | 11,659,000USD | 4,909,000USD | 17,556,000USD | 8,691,000USD | 13,332,000USD | 7,206,000USD | — |
| Total Operating Expenses | 26,575,000USD | 29,157,000USD | 18,483,000USD | 44,347,000USD | 23,084,000USD | 29,134,000USD | 13,529,000USD | 2,624,000USD |
| Operating Income | -26,575,000USD | -29,157,000USD | -19,298,000USD | -45,399,000USD | -23,116,000USD | -29,134,000USD | -13,529,000USD | -2,624,000USD |
| Interest Income | 520,000USD | 1,100,000USD | 90,000USD | — | — | — | — | — |
| Interest Expense | 207,000USD | 1,449,000USD | 507,000USD | 1,038,000USD | 134,000USD | 0USD | 0USD | — |
| Net Interest Income | 313,000USD | -1,504,000USD | 90,000USD | — | — | — | — | — |
| Income Before Tax | -26,262,000USD | -29,491,000USD | -19,208,000USD | -44,568,000USD | -27,177,000USD | -29,044,000USD | -13,510,000USD | -2,624,000USD |
| Tax Provision | 0USD | 0USD | 0USD | — | — | — | — | — |
| Net Income | -26,262,000USD | -29,491,000USD | -19,118,000USD | -44,568,000USD | -27,192,000USD | -29,044,000USD | -13,510,000USD | -2,725,000USD |
| Net Income From Continuing Ops | -26,262,000USD | -31,106,000USD | -19,208,000USD | — | — | — | — | — |
| Ebit | -26,055,000USD | -28,042,000USD | -19,208,000USD | -44,568,000USD | -27,043,000USD | -29,044,000USD | -13,529,000USD | — |
| Ebitda | -25,789,000USD | -27,661,000USD | -18,393,000USD | -43,516,000USD | -27,011,000USD | -28,813,000USD | -13,436,000USD | -2,624,000USD |
| Depreciation And Amortization | 266,000USD | 381,000USD | 815,000USD | 1,052,000USD | 32,000USD | 231,000USD | 93,000USD | — |
| Reconciled Depreciation | 266,000USD | 513,000USD | 339,000USD | — | — | — | — | — |
| Total Other Income Expense Net | 313,000USD | -334,000USD | 90,000USD | 831,000USD | -4,061,000USD | 90,000USD | 19,000USD | — |
| Cost Of Revenue | — | 381,000USD | 815,000USD | 1,052,000USD | 32,000USD | 231,000USD | 93,000USD | — |
| Gross Profit | — | -381,000USD | -815,000USD | -1,052,000USD | -32,000USD | — | — | — |
| Selling And Marketing Expenses | — | 381,000USD | — | — | — | — | — | — |
| Income Tax Expense | — | — | -90,000USD | 1,000USD | -169,000USD | 90,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | -19,208,000USD | -14,365,000USD | — | — | — | — |
| Unclassified Operating Expenses | — | — | — | -1,052,000USD | — | — | — | 1,454,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,633,000USD | 10,748,000USD | 16,931,000USD | 17,129,000USD | 24,484,000USD | 32,164,000USD | 41,488,000USD | 33,836,000USD |
| Cash And Equivalents | 779,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 1,697,000USD | 2,446,000USD | 8,269,000USD | 8,104,000USD | 15,103,000USD | 22,433,000USD | 31,474,000USD | 23,552,000USD |
| Other Current Assets | 417,000USD | 641,000USD | 562,000USD | 590,000USD | 823,000USD | 922,000USD | 1,206,000USD | 1,436,000USD |
| Other Non Current Assets | 501,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 10,723,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 4,450,000USD | 3,311,000USD | 3,314,000USD | 3,525,000USD | 7,141,000USD | 13,177,000USD | 14,220,000USD | 13,973,000USD |
| Other Current Liabilities | 715,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -1,090,000USD | 822,000USD | 6,668,000USD | 6,346,000USD | 9,783,000USD | 11,133,000USD | 19,126,000USD | 11,457,000USD |
| Total Equity Including Noncontrolling Interest | -1,090,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 7,435,000USD | 7,793,000USD | 8,145,000USD | 8,506,000USD | 8,852,000USD | 9,193,000USD | 9,529,000USD | 9,836,000USD |
| Accounts Payable | 1,995,000USD | 585,000USD | 1,038,000USD | 922,000USD | 4,716,000USD | 2,187,000USD | 2,450,000USD | 1,697,000USD |
| Short Term Debt | 1,287,000USD | 1,239,000USD | 1,192,000USD | 1,147,000USD | 1,103,000USD | 5,251,000USD | 7,223,000USD | 9,332,000USD |
| Common Stock | 16,000USD | 14,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 44,000USD | 27,000USD |
| Retained Earnings | -275,316,000USD | -270,072,000USD | -233,368,000USD | -229,347,000USD | -225,836,000USD | -217,966,000USD | -207,106,000USD | -193,293,000USD |
| Total Liab | — | 9,926,000USD | 10,263,000USD | 10,783,000USD | 14,701,000USD | 21,031,000USD | 22,362,000USD | 22,379,000USD |
| Other Current Liab | — | 1,487,000USD | 1,084,000USD | 1,456,000USD | 1,322,000USD | 5,739,000USD | 4,547,000USD | 2,944,000USD |
| Capital Stock | — | 14,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 44,000USD | 27,000USD |
| Cash | — | 1,805,000USD | 7,707,000USD | 7,514,000USD | 14,280,000USD | 21,511,000USD | 30,268,000USD | 22,116,000USD |
| Cash And Short Term Investments | — | 1,805,000USD | 7,707,000USD | 7,514,000USD | 14,280,000USD | 21,511,000USD | 30,268,000USD | 22,116,000USD |
| Net Debt | — | 6,049,000USD | 434,000USD | 891,000USD | -5,617,000USD | -8,406,000USD | -14,903,000USD | -4,378,000USD |
| Short Long Term Debt Total | — | 7,854,000USD | 8,141,000USD | 8,405,000USD | 8,663,000USD | 13,105,000USD | 15,365,000USD | 17,738,000USD |
| Property Plant Equipment Gross | — | 9,306,000USD | 9,598,000USD | 10,028,000USD | 10,307,000USD | 10,581,000USD | 10,849,000USD | 11,202,000USD |
| Common Stock Shares Outstanding | — | 10,931,593shares | 4,149,733shares | 4,440,111shares | 3,802,956shares | 3,437,671shares | 27,901,739shares | 25,806,825shares |
| Non Current Assets Total | — | 8,302,000USD | 8,662,000USD | 9,025,000USD | 9,381,000USD | 9,731,000USD | 10,014,000USD | 10,284,000USD |
| Non Current Liabilities Total | — | 6,615,000USD | 6,949,000USD | 7,258,000USD | 7,560,000USD | 7,854,000USD | 8,142,000USD | 8,406,000USD |
| Non Currrent Assets Other | — | 509,000USD | 517,000USD | 131,000USD | 529,000USD | 538,000USD | 485,000USD | 448,000USD |
| Net Working Capital | — | -865,000USD | 4,955,000USD | 4,579,000USD | 7,962,000USD | 9,256,000USD | 17,254,000USD | 9,579,000USD |
| Unclassified Non Current Liabilities | — | 6,615,000USD | 6,949,000USD | 7,258,000USD | 7,560,000USD | 7,854,000USD | 8,142,000USD | 8,406,000USD |
| Unclassified Equity | — | 270,866,000USD | 240,026,000USD | 235,685,000USD | 235,611,000USD | 229,091,000USD | 226,144,000USD | 204,696,000USD |
| Short Long Term Debt | — | — | — | — | — | 4,190,000USD | 6,354,000USD | 8,504,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | -4,190,000USD | -6,354,000USD | -8,504,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 16,931,000USD | 41,488,000USD | 51,603,000USD | 46,089,000USD | 73,238,000USD | 22,863,000USD | 74,970,000USD | 84,074,000USD |
| Other Current Assets | 562,000USD | 1,206,000USD | 1,133,000USD | 1,270,000USD | 2,134,000USD | 745,000USD | 6,344,000USD | 3,373,000USD |
| Total Liab | 10,263,000USD | 22,362,000USD | 24,835,000USD | 27,978,000USD | 37,121,000USD | 91,656,000USD | 15,099,000USD | 10,952,000USD |
| Total Stockholder Equity | 6,668,000USD | 19,126,000USD | 26,768,000USD | 18,111,000USD | 36,117,000USD | -68,793,000USD | 58,547,000USD | 70,951,000USD |
| Other Current Liab | 1,084,000USD | 4,547,000USD | 3,329,000USD | 4,756,000USD | 17,593,000USD | 1,439,000USD | 9,065,999USD | 7,630,000USD |
| Common Stock | 5,000USD | 44,000USD | 22,000USD | 11,000USD | 7,000USD | 1,000USD | 18,000USD | 13,000USD |
| Capital Stock | 5,000USD | 44,000USD | 22,000USD | 11,000USD | 7,000USD | 1,000USD | — | — |
| Retained Earnings | -233,368,000USD | -207,106,000USD | -165,263,000USD | -135,772,000USD | -100,063,000USD | -71,761,000USD | -208,654,000USD | -164,086,000USD |
| Cash | 7,707,000USD | 30,268,000USD | 39,230,000USD | 31,230,000USD | 51,829,000USD | 18,820,000USD | 63,512,000USD | 73,331,000USD |
| Cash And Short Term Investments | 7,707,000USD | 30,268,000USD | 39,230,000USD | 31,230,000USD | 51,829,000USD | 18,820,000USD | 63,512,000USD | 77,716,000USD |
| Total Current Assets | 8,269,000USD | 31,474,000USD | 40,363,000USD | 32,950,000USD | 68,963,000USD | 19,825,000USD | 71,132,000USD | 83,422,000USD |
| Total Current Liabilities | 3,314,000USD | 14,220,000USD | 9,411,000USD | 7,277,000USD | 20,026,000USD | 3,222,000USD | 12,520,000USD | 9,817,000USD |
| Net Debt | 434,000USD | -14,903,000USD | -18,569,000USD | -9,116,000USD | -33,292,000USD | -16,381,000USD | -58,990,000USD | -72,759,000USD |
| Short Term Debt | 1,192,000USD | 7,223,000USD | 5,237,000USD | 1,413,000USD | 1,442,000USD | 712,000USD | 1,959,000USD | 189,000USD |
| Short Long Term Debt Total | 8,141,000USD | 15,365,000USD | 20,661,000USD | 22,114,000USD | 18,537,000USD | 2,439,000USD | 4,522,000USD | 572,000USD |
| Accounts Payable | 1,038,000USD | 2,450,000USD | 845,000USD | 1,108,000USD | 991,000USD | 1,071,000USD | 1,495,000USD | 1,998,000USD |
| Property Plant Equipment Net | 8,145,000USD | 9,529,000USD | 10,792,000USD | 12,710,000USD | 4,164,000USD | 2,987,000USD | 3,331,000USD | — |
| Property Plant Equipment Gross | 9,598,000USD | 10,849,000USD | 11,817,000USD | 12,710,000USD | 4,988,000USD | 2,157,000USD | 3,331,000USD | — |
| Common Stock Shares Outstanding | 4,149,733shares | 27,902,000shares | 15,416,203shares | 888,378shares | 291,562shares | 31,210shares | 913,782shares | 103,136shares |
| Non Current Assets Total | 8,662,000USD | 10,014,000USD | 11,240,000USD | 13,139,000USD | 4,275,000USD | 3,038,000USD | 3,837,999USD | 652,000USD |
| Non Current Liabilities Total | 6,949,000USD | 8,142,000USD | 15,424,000USD | 20,701,000USD | 17,095,000USD | 88,434,000USD | 2,579,000USD | 1,135,000USD |
| Non Currrent Assets Other | 517,000USD | 97,000USD | 448,000USD | 429,000USD | 111,000USD | 51,000USD | 506,999USD | 213,000USD |
| Net Working Capital | 4,955,000USD | 17,254,000USD | 30,952,000USD | 25,673,000USD | 48,937,000USD | 16,603,000USD | — | — |
| Unclassified Non Current Liabilities | 6,949,000USD | 8,142,000USD | 9,160,000USD | 10,330,000USD | 2,026,000USD | 88,434,000USD | 2,579,000USD | 1,135,000USD |
| Unclassified Equity | 240,026,000USD | 226,144,000USD | 191,987,000USD | 153,861,000USD | 209,404,000USD | 2,514,000USD | 267,018,000USD | 234,876,000USD |
| Short Long Term Debt | — | 6,354,000USD | 4,285,000USD | — | — | — | — | — |
| Unclassified Current Liabilities | — | -6,354,000USD | -4,285,000USD | — | — | — | — | — |
| Long Term Debt | — | — | 6,264,000USD | 10,371,000USD | 15,069,000USD | — | — | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | 0USD | -73,238,000USD | 452,000USD | 165,000USD | 148,000USD |
| Other Assets | — | — | — | 0USD | 111,000USD | 2,508,000USD | 1USD | — |
| Net Receivables | — | — | — | 450,000USD | 15,000,000USD | 260,000USD | 1,276,000USD | 2,333,000USD |
| Inventory | — | — | — | — | 1,581,000USD | 686,000USD | — | — |
| Net Tangible Assets | — | — | — | — | 36,117,000USD | -68,793,000USD | -50,364,000USD | — |
| Unclassified Current Assets | — | — | — | — | -1,581,000USD | — | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | -2,508,000USD | — | — |
| Short Term Investments | — | — | — | — | — | — | — | 4,385,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 120,000USD |
| Change To Liabilities | 70,000USD |
| Change In Working Capital | -340,000USD |
| Operating Cash Flow | -10,377,000USD |
| Capital Expenditures | 0USD |
| Investing Cash Flow | 0USD |
| Net Debt Issuance | 0USD |
| Common Stock Issuance | 0USD |
| Unclassified Financing Cash Flow | 3,449,000USD |
| Financing Cash Flow | 3,449,000USD |
| Change In Cash | -6,928,000USD |
| End Cash Flow | 1,222,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -27,696,000USD | -4,021,000USD | -3,511,000USD | -7,870,000USD | -10,860,000USD | -13,813,000USD | -10,556,000USD | -9,570,000USD |
| Depreciation | 60,000USD | 65,000USD | 66,000USD | 67,000USD | 68,000USD | 49,000USD | 97,000USD | 155,000USD |
| Stock Based Compensation | 226,000USD | 576,000USD | 61,000USD | 1,092,000USD | 1,389,000USD | 1,331,000USD | 1,334,000USD | 1,320,000USD |
| Other Non Cash Items | 20,219,000USD | 293,000USD | 280,000USD | 312,000USD | 303,000USD | 309,000USD | 305,000USD | 410,000USD |
| Change In Working Capital | -407,000USD | -487,000USD | -3,675,000USD | -2,032,000USD | 1,064,000USD | 1,975,000USD | -1,362,000USD | 2,175,000USD |
| Total Cash From Operating Activities | -7,598,000USD | -3,574,000USD | -6,779,000USD | -8,431,000USD | -8,036,000USD | -10,149,000USD | -10,182,000USD | -5,510,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | -3,000USD | -3,000USD | -15,000USD | -249,000USD |
| Free Cash Flow | -7,598,000USD | -3,574,000USD | -6,779,000USD | -8,431,000USD | -8,036,000USD | -10,152,000USD | -10,197,000USD | -5,759,000USD |
| Net Borrowings | 0USD | 0USD | 0USD | -4,228,000USD | -2,198,000USD | -2,199,000USD | -2,199,000USD | — |
| Total Cash From Financing Activities | 1,696,000USD | 3,767,000USD | 13,000USD | 1,200,000USD | -721,000USD | 17,952,000USD | 1,541,000USD | 4,557,000USD |
| Issuance Of Capital Stock | 1,696,000USD | 2,316,000USD | -1,858,000USD | 5,428,000USD | 1,443,000USD | 20,152,000USD | 3,629,000USD | 4,557,000USD |
| Change In Cash | -5,902,000USD | 193,000USD | -6,766,000USD | -7,231,000USD | -8,757,000USD | 7,800,000USD | -8,656,000USD | -1,202,000USD |
| Begin Period Cash Flow | 8,150,000USD | 7,957,000USD | 14,723,000USD | 21,954,000USD | 30,711,000USD | 22,911,000USD | 31,567,000USD | 32,326,000USD |
| End Period Cash Flow | 2,248,000USD | 8,150,000USD | 7,957,000USD | 14,723,000USD | 21,954,000USD | 30,711,000USD | 22,911,000USD | 31,124,000USD |
| Other Cashflows From Financing Activities | 1,696,000USD | 3,767,000USD | 13,000USD | 1,858,000USD | -2,164,000USD | -1,000USD | 111,000USD | -249,000USD |
| Unclassified Financing Cash Flow | -1,696,000USD | -2,316,000USD | 1,858,000USD | -1,858,000USD | 2,198,000USD | — | — | — |
| Investments | — | — | 0USD | 0USD | 0USD | -3,000USD | -15,000USD | -249,000USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | -3,000USD | -15,000USD | -249,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -26,262,000USD | -41,843,000USD | -29,491,000USD | -35,709,000USD | -28,302,000USD | -19,208,000USD | -44,568,000USD | -27,192,000USD |
| Depreciation | 266,000USD | 389,000USD | 381,000USD | 638,000USD | 374,000USD | 339,000USD | 1,052,000USD | 32,000USD |
| Stock Based Compensation | 3,118,000USD | 5,303,000USD | 2,546,000USD | 1,561,000USD | 1,105,000USD | 453,000USD | 310,000USD | 1,427,000USD |
| Other Non Cash Items | 1,188,000USD | 1,511,000USD | 1,884,000USD | 1,570,000USD | 1,479,000USD | 470,000USD | 4,347,000USD | 2,221,000USD |
| Change In Working Capital | -5,130,000USD | 1,613,000USD | -2,677,000USD | 868,000USD | -613,000USD | -1,071,000USD | -2,053,000USD | 1,036,000USD |
| Total Cash From Operating Activities | -26,820,000USD | -33,027,000USD | -27,357,000USD | -31,072,000USD | -25,957,000USD | -19,017,000USD | -41,222,000USD | -23,647,000USD |
| Capital Expenditures | 0USD | -435,000USD | -170,000USD | -562,000USD | -135,000USD | -50,000USD | -397,000USD | -36,000USD |
| Free Cash Flow | -26,820,000USD | -33,462,000USD | -27,527,000USD | -31,634,000USD | -26,092,000USD | -19,067,000USD | -41,619,000USD | -23,683,000USD |
| Net Borrowings | -6,426,000USD | -4,398,000USD | 0USD | -4,739,000USD | 15,000,000USD | 15,000,000USD | 15,000,000USD | — |
| Total Cash From Financing Activities | 4,259,000USD | 24,500,000USD | 35,602,000USD | 11,403,000USD | 59,063,000USD | 34,599,000USD | 26,943,000USD | 78,552,000USD |
| Issuance Of Capital Stock | 7,329,000USD | 28,591,000USD | 1,266,000USD | 16,142,000USD | 33,425,000USD | 35,000,000USD | — | — |
| Change In Cash | -22,561,000USD | -8,962,000USD | 8,075,000USD | -20,231,000USD | 33,009,000USD | 15,576,000USD | -9,819,000USD | 55,708,000USD |
| Begin Period Cash Flow | 30,711,000USD | 39,673,000USD | 31,598,000USD | 51,829,000USD | 18,820,000USD | 3,244,000USD | 73,331,000USD | 17,623,000USD |
| End Period Cash Flow | 8,150,000USD | 30,711,000USD | 39,673,000USD | 31,598,000USD | 51,829,000USD | 18,820,000USD | 63,512,000USD | 73,331,000USD |
| Other Cashflows From Financing Activities | 4,259,000USD | 307,000USD | -170,000USD | 7,281,000USD | 10,638,000USD | 34,599,000USD | 27,145,000USD | 33,316,000USD |
| Investments | — | -435,000USD | -519,000USD | -562,000USD | -97,000USD | -6,000USD | — | — |
| Total Cashflows From Investing Activities | — | -435,000USD | -170,000USD | -562,000USD | -97,000USD | -6,000USD | 3,988,000USD | 1,124,000USD |
| Unclassified Financing Cash Flow | — | — | 34,506,000USD | -7,281,000USD | — | -50,000,000USD | -15,202,000USD | 45,236,000USD |
| Change To Liabilities | — | — | — | — | -209,000USD | -574,000USD | 954,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | 38,000USD | 44,000USD | 44,000USD | 476,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | 4,341,000USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -1,171,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.